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Abstract 
Objective: Dystroglycan (DG) is an adhesion complex formed by two subunits, α-DG and β-DG. In skeletal muscle, 
DG is part of the dystrophin-glycoprotein complex that is crucial for sarcolemma stability and it is involved in a pleth-
ora of muscular dystrophy phenotypes. Due to the important role played by DG in skeletal muscle stability as well as 
in a wide variety of other tissues including brain and the peripheral nervous system, it is essential to investigate its 
genetic assembly and transcriptional regulation.
Results: Herein, we analyze the effect of the insertion of a floxed neomycin (Neo) cassette within the 3′ portion of 
the universally conserved IG1-intron of the DG gene (Dag1). We analyzed the transcription level of Dag1 and the 
expression of the DG protein in skeletal muscle of targeted mice compared to wild-type and we did not find any 
alterations that might be attributed to the gene targeting. However, we found an increase of the cross-sectional areas 
of tibialis anterior that might have some physiological significance that needs to be assessed in the future. Moreover, 
in targeted mice the skeletal muscle morphology and its regeneration capacity after injury did not show any evident 
alterations. We confirmed that the targeting of Dag1 with a floxed Neo-cassette did not produce any gross undesired 
effects.
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Introduction
Dystroglycan (DG) is a widely expressed adhesion com-
plex encoded by a single gene (Dag1) as a unique precur-
sor that undergoes post-translational cleavage to generate 
two interacting subunits: the extracellular and highly gly-
cosylated α-DG and the transmembrane β-DG [1, 2].
DG is crucial for cell membrane stability connect-
ing the actin cytoskeleton to extracellular matrix (ECM) 
proteins [3]. Whenever the DG/ECM axis is perturbed, 
severe muscular dystrophy phenotypes do arise [4, 5].
Extensive genetic work has been carried out in order to 
analyze the function of DG in several tissues [6]. It was 
shown that the knockout of Dag1 in mice is embryonic 
lethal [7]. This result is in line with what was observed 
in some human patients, in which a homozygous loss-of-
function mutation in Dag1 results in the absence of DG 
that leads to early postnatal lethality [8].
Conditional knockouts of Dag1 in several tissues have 
confirmed the importance of DG for tissue stability. In 
those studies, no apparent effects of the inserted floxed 
Neo cassette have been reported [9–11]. Moreover, the 
knock-in mouse carrying the pathological mutation 
T190M  showed an evident muscular dystrophy pheno-
type and possible effects arising from the presence of the 
exogenous genetic elements might have been covered up 
[12]. On the other hand, in the knock-in mouse Y890F 
the floxed-Neo cassette had been already removed in the 
chimeric mice and no effect arising from the presence of 
the remaining LoxP element has been reported [13].
Interestingly, the insertion of a floxed Neo-cassette 
can lead to a significantly reduced expression of the tar-
get gene and can also downregulate the transcription of 
genes located at a distance of several kilobases from it 
[14–22].
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Considering the lack of experimental data on the 
effects of the floxed Neo cassette on Dag1 expres-
sion, we have decided to assess whether the presence 
of a floxed Neo cassette or single floxed site in the 
Dag1 allele might have per se some evident func-
tional consequences for Dag1 expression in skeletal 
muscle.
Main text
Methods
Generation of targeting vector
Genomic DNA from V6.4 murine ES (embryonic stem) 
cells, (genotype C57BL/6J  ×  129/SvJae), was used as a 
template to amplify the right and left hand arms of the 
DG targeting construct. The 5′ arm of the construct 
consisted of 3.2  kb of intronic sequences amplified 
from the Dag1 intron using the following primers: for-
ward 5′-GAGTAAGACTTTGTCTATAAAACA-3′ and 
reverse 5′-AAACCCCAACAACTACGGTCCTCA-3′. 
The 3′ arm was 4  kb in length, consisted of the exon 3 
region, harboring four mutations, flanked by intronic 
sequences and the 3′-UTR, respectively, was ampli-
fied using the following primers: forward 5′-GAGA-
AGTGGGATTCATTTAGACAG-3′ and reverse 
5′GAATGTAATCTTTAGCTACTGTT-3′. To allow the 
linearization of the targeting vector that is necessary for 
the recombination and integration of the construct into 
the ES cells genome, site-directed mutagenesis was used 
to mutate a XhoI site in the 5′ arm using the QuikChange 
site-directed mutagenesis kit  (Stratagene®) and the fol-
lowing primers: forward 5′-AGTTCCTTCCTGCCTA 
GAGTGGGTGTTCCCT-3′ and reverse 5′-AGGGAAC 
ACCCACTCTAGGCAGGAAGGAACT-3′ (mutated 
nucleotides in bold). Both the right and left hand arms 
were initially cloned into separate TOPO vectors (Invit-
rogen) and then sub-cloned into the final targeting vec-
tor, a modified pBluescript KS vector containing a floxed 
neomycin cassette under the PGK promoter (Fig.  1a). 
The 5′ and 3′ arms were cloned within a BamHI and 
HindIII sites respectively. Both enzymes (New England 
 Biolabs® Inc) were incubated at 37 °C for 1.5 h. The Her-
pes simplex thymidine kinase (HSVtk) cassette acts as a 
negative selection marker. The targeting vector was used 
at the Core Facility for Conditional Mutagenesis, Dibit-
San Raffaele Scientific Institute, Milan to electropo-
rate and analyze murine ES cells by Southern blot. One 
homologous recombinant ES clone was microinjected 
into blastocysts from 129 J mice. The resulting chimeras 
were then bred with C57BL6 mice to generate germ line-
transmitted heterozygous mice (Dag1Neo/+). Dag1Neo/+ 
mice were backcrossed into the C57BL/6 background for 
ten generations and then used to create the experimental 
colonies. Mice from different colonies were crossbred to 
generate wild-type (Dag1+/+), heterozygous (Dag1Neo/+) 
and homozygous mice (Dag1Neo/Neo).
To remove the Neo cassette, homozygotes were cross-
bred with male transgenic mice expressing the transgene 
Cre under the CMV promoter (Jackson Laboratories) to 
generate Dag1Neo/+ mice. Female F1 animals were bred 
again with homozygous Dag1Neo/Neo mice to generate 
Dag1ΔNeo/ΔNeo mice.
Creatine kinase assay
Fresh serum was collected by retro-orbital bleeding. The 
creatine kinase (CK) level was determined according to 
the International Federation of Clinical Chemistry with 
commercial reagents on the Cobas 8000/c701® (Roche 
Diagnostics).
Histological and immunofluorescence analysis
All the analyses described below were not performed 
blind. Tibialis anterior (TA) and gastrocnemius (GA) 
muscles of 5  months-old female mice (n =  4 per geno-
type) were embedded in Jung tissue freezing medium 
and frozen in liquid nitrogen-cooled isopentane. Frozen 
sections (7 μm) were stained with hematoxylin and eosin 
(HE) using standard methods [23]. Fiber cross-sectional 
areas (CSA) of muscle sections were counted manually 
using ImageJ (NIH, Bethesda, MD) from 6 to 12 ran-
domly selected fields per section. At least 150 fibres per 
mouse from three mice per genotype were counted.
For the immunofluorescences analysis, TA muscle fro-
zen sections of 5 months-old female mice were incubated 
with the following antibodies diluted in PBS containing 
1% BSA (Sigma-Aldrich): mouse monoclonal anti-α-DG 
IIH6 (Millipore, code 05–593) (1:100), rabbit polyclonal 
anti-β-DG (Abcam, code ab43125) (1:300) and rat mono-
clonal anti-laminin-α2 clone 4H8-2 (Sigma-Aldrich, code 
L0663) (1:100). The primary antibodies were followed 
by the appropriate secondary goat anti-mouse IgM (for 
IIH6), goat anti mouse, anti rat or anti rabbit IgG antibod-
ies conjugated with  Alexa®488 or  Alexa®633 fluorophores 
(1:500) (Invitrogen-Thermo Fisher Scientific). Muscle sec-
tions incubated with the only secondary antibody were 
used as control to validate the primary antibody specific-
ity. Sections were viewed with a Leica SP2 microscope and 
all images were analyzed using ImageJ software (NIH).
Cardiotoxin injury
TA muscles of female 5 months-old mice (four mice per 
group) were injured along the entire length of the muscle 
with cardiotoxin (CTX) (LATOXAN SAS, code L8102) 
injections, 5 μL of 10 μM CTX in saline solution. These 
conditions ensured muscle damage a uniform manner. 
The muscles were harvested 10  days after cardiotoxin-
induced damage. Frozen sections were processed for 
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histological analysis. Contralateral intact muscles were 
used as a control. In our previous study, regeneration 
was fully active at 7 days after injury [24]. Sections were 
viewed with a Leica SP2 microscope and all images were 
analyzed using ImageJ software (NIH).
Western blotting
TA muscle proteins from 5  months-old mice were 
extracted with PBS 1% Triton-X100 containing pro-
tease inhibitors. 20 μg of soluble proteins were analyzed 
in  Western blot as described elsewhere [24] using the 
following antibodies: anti mouse α-DG IIH6 (Millipore) 
(1:1000), anti rabbit β-DG (Abcam) (1:1000) and anti-
tubulin HRP-conjugated (Abcam) antibodies.
RT‑PCR
RNA was isolated from frozen muscle using the RNeasy 
Fibrous Tissue Mini Kit. Reverse Trascriptase PCR reac-
tions were carried out using 3  μg of RNA. Quantitative 
RT-PCR was performed in triplicate using a standard 
 TaqMan® PCR protocol on a StepOne Real time PCR 
System (Applied Biosystems). Probes were specific for 
mouse Dag1 and mouse Gadph genes. Data analysis was 
performed as described elsewhere [25].
Fig. 1 Organization of the dystroglycan gene and position of the floxed Neo cassette. a Schematic representation of the Dag1+/+ allele, the 
targeting vector, the Dag1 allele after incomplete homologous recombination (Dag1Neo) and the neo-deleted allele (Dag1ΔNeo). The 5′ arm of the 
construct consisted of a 3.2 kb fragment amplified from the Dag1 intron. The 3′ arm was 4 kb in length and consisted of the exon 3′ region, har-
bouring four mutations (red asterisks) hitting the α/β-DG interface, and flanked by intronic sequences and the 3′-UTR, respectively. A XhoI (X) site in 
the 5′ arm was mutated for cloning purposes. The floxed neomycin cassette (Neo) and the Herpes simplex thymidine kinase (TK) acted as positive 
and negative selection markers, respectively. Selected restriction enzyme cleavage sites are indicated above the gene (B: BamHI; H: HindIII and X: 
XhoI). Primers used for genotyping are also indicated as black arrows. b A representative PCR genotyping analysis of the Dag1Neo/+ mouse. The PCR 
product was amplified from genomic DNA using primers spanning the Neo cassette region
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Statistical analysis
Data  were expressed as mean  ±  standard error of the 
mean (SE). Comparisons among groups were performed 
using an analysis of variance (One-way ANOVA) fol-
lowed by a Bonferroni’s post hoc multiple comparison 
test to determine statistical significance of the differ-
ences among the four experimental mice groups; p value 
of  <  0.05 was considered to be statistically significant. 
Statistical analyses were performed with SPSS software 
(version 17.0, Chicago, IL, US).
Results and discussion
Insertion of the floxed Neo cassette into Dag1 and removal 
by Cre recombinase: the Dag1Neo/Neo and Dag1ΔNeo/ΔNeo mouse 
lines
In an attempt to produce a novel DG knock-in mouse 
line harboring four mutations at the α/β-DG interface 
[26], an incomplete homologous recombination at the 
3′ arm (Fig.  1) prevented the generation of the desired 
mutated mouse line. Indeed, we generated and studied 
a mouse line with a Dag1 allele in which a Neo cassette, 
flanked by two LoxP sites, was inserted into the second 
intron (Dag1Neo allele) (Fig. 1).
The Neo cassette was introduced in the second intron 
(also termed IG1-intron since it interrupts the struc-
ture of the IG1 domain within the structurally autono-
mous N-terminal region of α-DG [27]). In addition, we 
have also crossbred our mice with a mouse line that 
expresses the Cre recombinase under a CMV-promoter 
and results in Cre-mediated recombination in germ line. 
This resulted in the Cre-driven excision of the floxed Neo 
cassette in the targeted Dag1 (Dag1ΔNeo allele, Fig. 1a, b).
Histological and molecular analysis of skeletal muscle
Animals with two wild-type alleles are denoted by 
“Dag1+/+”, mouse lines in which one allele carries the 
floxed Neo cassette are designated “Dag1Neo/+”, whilst 
their homozygous counterpart is denoted by “Dag1Neo/
Dag1+/+ Dag1Neo/+
Dag1Neo/Neo Dag1∆Neo/∆Neo
_
_ _
_
Fig. 2 Histological analysis of skeletal muscle. Hematoxylin and eosin staining of transverse frozen sections of tibialis anterior muscle of 5 months 
old Dag1+/+, Dag1Neo/+, Dag1Neo/Neo, and Dag1ΔNeo/ΔNeo female mice (4 mice per group). No dramatic abnormalities were observed in the skeletal 
muscle morphology of the targeted mice compared to their wild-type counterparts. Scale bar = 50 μm
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Dag1+/+ Dag1+/+ Dag1+/+
Dag1Neo/+Dag1Neo/+Dag1Neo/+
Dag1Neo/Neo Dag1Neo/Neo Dag1Neo/Neo
Dag1∆Neo/∆Neo Dag1∆Neo/∆Neo Dag1∆Neo/∆Neo
a
b
Fig. 3 Immunofluorescence staining of skeletal muscle tissue sections. Immunolabeling of a α-DG and b β-DG and laminin-α2 of 5 months old 
mice tibialis anterior muscle. Scale bar = 20 μm
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Neo”. Finally, “Dag1ΔNeo/ΔNeo” indicates the mouse line 
obtained upon the excision of the  Neo cassette by Cre 
recombinase.
At 5  months of age, body weights of Dag1Neo/+ (male 
31.5  g  ±  2.3; female 25  g  ±  1.7), Dag1Neo/Neo (male 
31.7  g  ±  2.6; female 24.5  g  ±  1.5) and Dag1ΔNeo/ΔNeo 
(male 31.8  g  ±  2.2; female 26  g  ±  1.1) mice were not 
significantly different from wild-type controls (male 
31.8 g ± 2.5; female 25 g ± 1.5).
Histology of tibialis anterior (TA) and gastrocnemius 
(GA) muscles of 5 months-old female mice, derived from 
crosses between heterozygotes (intercross) belonging to 
different colonies, examined by HE staining did not show 
any gross morphological sign indicating skeletal muscle 
alterations in Dag1Neo/+, Dag1Neo/Neo, and Dag1ΔNeo/ΔNeo 
mice compared to Dag1+/+ controls (Fig.  2). In all the 
Dag1 targeted mice, the levels of serum CK, a marker 
for skeletal muscle damage, did not significantly differ 
from those of wild-type animals (female: Dag1+/+ 366 
U/L  ±  0.8; Dag1Neo/+ 370 U/L  ±  0.8; Dag1Neo/Neo 355 
U/L ± 0.7; Dag1ΔNeo/ΔNeo 360 U/L ± 0.85). CK was meas-
ured in 3 and 5-months old mice. Immunofluorescence 
analysis showed the expected localization of the two 
DG subunits as well as of the DG major skeletal muscle 
binding partner laminin to the cell membrane and cell 
surface, respectively (Fig.  3). Western blot analysis con-
firmed that the DG precursor is correctly cleaved into its 
two subunits and that α-DG is highly glycosylated in all 
the lines (Fig. 4a). The levels of α- and β-DG were similar 
compared to wild-type mice (data not shown).
Next, we examined the muscle fiber cross-sectional 
areas (CSA) by sampling a set of muscle fiber size in TA 
(Fig. 5a) and GA (Fig. 5b) muscle within the four experi-
mental groups (four mice per group). Overall, we found 
a significant difference of the medians of fiber CSAs 
between the groups (lines) of mice (p < 0.001) whereas in 
GA we did not find any difference (p = 0.998). In particu-
lar, in TA muscle the CSA in mouse line Dag1ΔNeo/ΔNeo 
(mean 1826 μm2 ± 37) was significantly increased when 
compared with Dag1+/+ mice (mean 1609  μm2  ±  36) 
(p  <  0.001). At present, we cannot rule out that the 
observed variability in TA might have significant physi-
ological repercussions. Further investigations will be 
required to better clarify this point.
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Fig. 4 Western blot analysis. Representative immunoblotting of total 
protein lysates from Dag1+/+, Dag1Neo/+, Dag1Neo/Neo, and Dag1ΔNeo/
ΔNeo skeletal muscle. Upper panel; α-DG probed with IIH6 antibody 
specific for the α-DG carbohydrates epitopes; middle panel: tubulin 
used as loading control; lower panel: β-DG probed with the anti 
43-DAG antibody showing the correct processing of the DG precursor
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Fig. 5 Analysis of skeletal muscle fiber cross-sectional areas (CSA). 
a Tibialis anterior (TA) muscle and b gastrocnemius (GA) muscle of 
Dag1+/+, Dag1Neo/+, Dag1Neo/Neo, and Dag1ΔNeo/ΔNeo 5-months old 
female mice (4 mice per group). *Indicates significant difference 
(p < 0.001). Error bars represent SEM
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The increase of TA muscle fibers was not mirrored by 
an increase either in DG protein levels or in Dag1 tran-
scription (see below) (Figs. 4, 6). The Dag1 transcription 
levels were measured by Real Time PCR experiments that 
monitor the changes in mRNA levels of Dag1Neo/Neo, and 
Dag1ΔNeo/ΔNeo mice relative to Dag1+/+ littermates and no 
significant change was detected (p = 0.707) (Fig. 6).
Cardiotoxin‑induced skeletal muscle regeneration
Dystroglycan is essential for postnatal muscle growth, 
stability and regeneration [9, 28]. To further analyze 
the possible presence of skeletal muscle defects of the 
regenerative process, we analyzed the TA muscles of 
Dag1Neo/+, Dag1Neo/Neo, and Dag1ΔNeo/ΔNeo 5-months 
old female mice compared to Dag1+/+ mice, 10  days 
after CTX-induced damage. HE staining revealed that, 
although CTX injection caused muscle necrosis with 
the accumulation of mononucleated infiltrating cells, the 
regeneration response occurred in all the analysed mus-
cles, as demonstrated by the amount of central nucleated 
fibers present (p = 0.559) (Fig. 7).
Limitations
The targeting of Dag1 with a floxed  Neo cassette did 
not produce any strong undesired skeletal muscle phe-
notype. The increase of CSA that we observed in TA of 
Dag1ΔNeo/ΔNeo mice might be due to some degree of vari-
ability between the analyzed mice, but must be further 
analyzed. Dag1 second  intron is large (10  Kb) and this 
justifies the absence of relevant effects on Dag1 mRNA 
upon the introduction of the floxed Neo-cassette [29].
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Dag1Neo/+, Dag1Neo/Neo, and Dag1ΔNeo/ΔNeo mice. Skeletal muscle 
regeneration process after CTX injection was not affected in Dag-
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groups (p = 0.559). Error bars represent SEM
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